Immunocore Holdings IMCR
NASDAQ IMCR
$31.71 -0.67 (-2.07%)
As of: Nov 11, 2026 · 12:17 PM EST

Immunocore Holdings (IMCR) Non-Current Deferred Revenue (2022 - 2026)

Updated

Immunocore Holdings (IMCR) posted Non-Current Deffered Revenue of $4.49 million for Q2 2026, down 14.4% from $5.25 million a year earlier and down 2.9% from the prior quarter.

Analysis

Immunocore Holdings (IMCR) Non-Current Deferred Revenue (2022 - 2026) Analysis & Trends

At the end of FY2025, Immunocore Holdings' Non-Current Deffered Revenue came in at $4.86 million, down 10.6% from FY2024.

  • Annual Non-Current Deffered Revenue shows a three-year compound annual growth rate of -2.5% (FY2022 to FY2025).
  • In prior years, Immunocore Holdings' Non-Current Deffered Revenue was $5.43 million in FY2024 (-1.5%), $5.52 million in FY2023 (+5.2%) and $5.24 million in FY2022.
  • The Q2 2026 figure stands as the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2022.
  • On a year-over-year basis, Non-Current Deffered Revenue has declined in each of the last five quarters, with an average decline of 8.5% over the last seven quarters.
  • The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q4 2023, with growth of 5.2%; the weakest was Q1 2026, with a decline of 17.6%.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $4.62 million (Q1 2026), $4.86 million (Q4 2025) and $5 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Immunocore Holdings 1.67 Bn -1.82 Bn 101.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.34 Mn
Jun 30, 2026 4.49 Mn
Mar 31, 2026 4.62 Mn
Dec 31, 2025 4.86 Mn
Sep 30, 2025 5.00 Mn
Jun 30, 2025 5.25 Mn
Mar 31, 2025 5.61 Mn
Dec 31, 2024 5.43 Mn
Sep 30, 2024 5.80 Mn
Jun 30, 2024 5.48 Mn
Mar 31, 2024 5.47 Mn
Dec 31, 2023 5.52 Mn
Dec 31, 2022 5.24 Mn
API Access

Immunocore Holdings Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IMCR&period=max&api_key=YOUR_API_KEY